BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 10178645)

  • 1. Pharmacoeconomics in the new millennium. A pharmaceutical industry perspective.
    Thwaites R; Townsend RJ
    Pharmacoeconomics; 1998 Feb; 13(2):175-80. PubMed ID: 10178645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacoeconomics - Challenges for Health Professionals].
    Turčić P; Benković V; Brborović O; Valent A
    Acta Med Croatica; 2016 Apr; 70(2):117-23. PubMed ID: 28722840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging role of pharmacoeconomics in the research and development decision-making process.
    DiMasi JA; Caglarcan E; Wood-Armany M
    Pharmacoeconomics; 2001; 19(7):753-66. PubMed ID: 11548911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penny and pound wise: pharmacoeconomics from a governmental perspective.
    van Oostenbruggen MF; Jansen RB; Mur K; Kooijman H
    Pharmacoeconomics; 2005; 23(3):219-26. PubMed ID: 15836004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of colleges of pharmacy in meeting the pharmacoeconomic needs of the pharmaceutical industry: a conference report.
    Draugalis JR; Coons SJ
    Clin Ther; 1994; 16(3):523-37; discussion 522. PubMed ID: 7923318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Science, pharmacoeconomics and ethics in drug R&D: a sustainable future scenario?
    Preziosi P
    Nat Rev Drug Discov; 2004 Jun; 3(6):521-6. PubMed ID: 15173841
    [No Abstract]   [Full Text] [Related]  

  • 7. What is next for pharmacoeconomics and outcomes research in Asia?
    Doherty J; Kamae I; Lee KK; Li H; Li SC; Liu GG; Tarn YH; Yang BM
    Value Health; 2004; 7(2):118-32. PubMed ID: 15164802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoeconomics and formulary decision making.
    Sanchez LA
    Pharmacoeconomics; 1996; 9 Suppl 1():16-25. PubMed ID: 10160112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacoeconomic impact of compliance].
    Agh T; Mészáros A
    Acta Pharm Hung; 2010; 80(2):75-80. PubMed ID: 20684381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoeconomics and immunotherapy.
    Berto P
    Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():12-6. PubMed ID: 18924461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to implementing pharmacoeconomics: interview study.
    Alefan Q; Hamdouni E; Alhamad H; Mukattash T; Rascati K
    Expert Rev Pharmacoecon Outcomes Res; 2021 Feb; 21(1):93-104. PubMed ID: 32394752
    [No Abstract]   [Full Text] [Related]  

  • 12. How to improve pharmacoeconomic data generalisability between different countries.
    Li SC
    Expert Opin Pharmacother; 2007 Jul; 8(10):1409-13. PubMed ID: 17661723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PharmacoEconomics. Foreword.
    Milne CP
    Pharmacoeconomics; 2006 Dec; 24 Suppl 2():1-3. PubMed ID: 23389483
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of pharmacoeconomic analysis in R&D decision making: when, where, how?
    Miller P
    Pharmacoeconomics; 2005; 23(1):1-12. PubMed ID: 15693724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical economy and the economic assessment of drugs in France.
    le Pen C
    Soc Sci Med; 1997 Aug; 45(4):635-43. PubMed ID: 9226787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoeconomics and health policy. Current applications and prospects for the future.
    Greenberg PE; Arcelus A; Birnbaum HG; Cremieux PY; LeLorier J; Ouellette P; Slavin MB
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):425-32. PubMed ID: 10662390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoeconomics comes of age?
    Walley T; Breckenridge A
    Clin Pharmacol Ther; 2008 Aug; 84(2):279-80. PubMed ID: 18563057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacoeconomics in contemporary medicine].
    Czech M
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():16-9. PubMed ID: 15524007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
    Führlinger S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacy benefit management: enhancing the applicability of pharmacoeconomics for optimal decision making.
    Mullins CD; Wang J
    Pharmacoeconomics; 2002; 20(1):9-21. PubMed ID: 11817989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.